Therapy News and Research

RSS

TxCell to receive US patent for Ovasave to treat inflammatory bowel disease

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today announces that a key patent is to be granted on March 31 2015 by the United States Patent and Trademark Office.

19 Mar 2015

Austrian Centre of Industrial Biotechnology develops method to reduce production costs of valuable drugs

Imagine a loved relative suffering from cancer - and you could not afford a treatment because the drugs are too expensive. The Austrian Centre of Industrial Biotechnology (acib) developed a method with the power to reduce production costs of highly valued drugs significantly.

19 Mar 2015

PaMZ drug regimen shows potential to improve treatment for MDR-TB

A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.

19 Mar 2015

Researchers discover new cause to explain development of temporal lobe epilepsy

Epilepsy is a very prevalent neurological disorder. Approximately one-third of patients are resistant to currently available therapies. A team of researchers under the guidance of the Institute of Cellular Neurosciences at the University of Bonn has discovered a new cause to explain the development of temporal lobe epilepsy: At an early stage, astrocytes are uncoupled from each other.

19 Mar 2015

UVA researcher identifies potential therapeutic target for myotonic muscular dystrophy

A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could modify progression of muscle damage and muscle dysfunction associated with the disease - issues that cause patients significant disability and deterioration in quality of life.

19 Mar 2015

New radiation treatment for brain cancer implanted in first human being at CTRC

David Williams is the first human being ever to have a new radiation treatment implanted in the center of his brain tumor.

18 Mar 2015

New research identifies promising drug therapy target for breast cancer

The genome of a cell is under constant attack, suffering DNA damage that requires an army of repair mechanisms to keep the cell healthy and alive. Understanding the behavior of the enzymes defending these assaults helps determine how - and where - cancer gets its foothold and flourishes.

18 Mar 2015

Researchers identify promising new approach to treat pulmonary fibrosis

By uncovering the mechanism by which fibrous tissue cells in the lung multiply, researchers at The Saban Research Institute of Children's Hospital Los Angeles, along with colleagues in Mexico and Canada, have identified a promising new approach for the treatment of pulmonary fibrosis.

18 Mar 2015

TSRI scientists successfully test potential preventative therapy for type 1 diabetes in animal models

Scientists from the Florida campus of The Scripps Research Institute have successfully tested a potent synthetic compound that prevents type 1 diabetes in animal models of the disease.

18 Mar 2015

Laura De Laporte receives ERC grant to develop minimally invasive therapy for spinal cord injury

The research objective of Dr.-Ing. Laura De Laporte, junior group leader at DWI - Leibniz Institute for Interactive Materials in Aachen, is to develop a minimally invasive therapy for spinal cord injury. Her goal and her scientific approach to develop an injectable material with the ability to provide biochemical and physical guidance for regenerating nerves across the injury site, was selected by the European Research Council.

18 Mar 2015

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM (cholic acid) as a once-daily treatment for cholic acid deficiency in bile acid synthesis disorders due to single enzyme defects.

18 Mar 2015

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Pharmalink AB, a specialty pharma company, announces that it has acquired a novel product candidate in development for treating inflammation from Synartro AB. No financial details are disclosed.

18 Mar 2015

PVNF gifts $1,250,000 to support Alzheimer's research at UT Southwestern

Presbyterian Village North Foundation has made two gifts totaling $1,250,000 to support Alzheimer's research at UT Southwestern Medical Center.

18 Mar 2015

Study investigates effects of antidepressant treatment in pain catastrophizing patients

A select population of patients having surgery experience what is called pain catastrophizing - an irrational thought process that leads a patient to perceive pain as worse than it actually is. Antidepressant medications reduce negative mood and might change this way of thinking, but according to a study published in the April edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, that may not be the case, at least for acute pain.

18 Mar 2015

Students attending Brainworks program to learn how regular exercise may help improve brain health

About 140 seventh- and eighth-graders attending Cedars-Sinai's Brainworks program March 23 will learn how hopping, skipping, jumping and other elements of a regular exercise routine may help improve brain health. An exercise station - a new feature of the 17-year-old program - will be one of nine areas where students will interact with Cedars-Sinai neurosurgeons, neurologists, neuroscientists and other health professionals.

18 Mar 2015

Physicians, researchers to discuss advances in cancer immunotherapies at UChicago symposium

The Ben May Department for Cancer Research at the University of Chicago will hold a day-long symposium on cancer immunotherapy for physicians and researchers.

18 Mar 2015

Simultaneous use of hormones and statins can protect women from heart disease after menopause

Hormones may not protect women from heart disease or stroke after menopause, but when combined with cholesterol-lowering statin drugs, they may help protect women from these killers, shows a population study from Sweden to be published in the April issue of Menopause, the journal of The North American Menopause Society.

18 Mar 2015

Extended dual antiplatelet therapy after DES implantation increases mortality

Data from a meta-analysis published today in The Lancet found that extended duration dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation was associated with significantly higher rates of mortality compared to shorter DAPT.

18 Mar 2015

Patients who experience deadliest form of heart attack may benefit from angioplasty

Patients who experience the deadliest form of heart attack--ST segment elevation myocardial infarction (STEMI)--and suffer from substantial narrowing in multiple heart arteries may benefit from receiving angioplasty in constricted arteries not affected by the heart attack, thereby reducing the need for future angioplasty, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.

18 Mar 2015

Medigus announces completion of three MUSE procedures for GERD treatment in Italy

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan.

18 Mar 2015

Therapy News and Research

TxCell to receive US patent for Ovasave to treat inflammatory bowel disease

Austrian Centre of Industrial Biotechnology develops method to reduce production costs of valuable drugs

PaMZ drug regimen shows potential to improve treatment for MDR-TB

Researchers discover new cause to explain development of temporal lobe epilepsy

UVA researcher identifies potential therapeutic target for myotonic muscular dystrophy

New radiation treatment for brain cancer implanted in first human being at CTRC

New research identifies promising drug therapy target for breast cancer

Researchers identify promising new approach to treat pulmonary fibrosis

TSRI scientists successfully test potential preventative therapy for type 1 diabetes in animal models

Laura De Laporte receives ERC grant to develop minimally invasive therapy for spinal cord injury

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

PVNF gifts $1,250,000 to support Alzheimer's research at UT Southwestern

Study investigates effects of antidepressant treatment in pain catastrophizing patients

Students attending Brainworks program to learn how regular exercise may help improve brain health

Physicians, researchers to discuss advances in cancer immunotherapies at UChicago symposium

Simultaneous use of hormones and statins can protect women from heart disease after menopause

Extended dual antiplatelet therapy after DES implantation increases mortality

Patients who experience deadliest form of heart attack may benefit from angioplasty

Medigus announces completion of three MUSE procedures for GERD treatment in Italy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News